Akèy › Nakolepsi
Etid klinik pou Nakolepsi ap rekrite nan Etazini
15 etid pou Nakolepsi ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Cincinnati, OH7 etid
- Miami, FL7 etid
- Charlotte, NC6 etid
- Columbia, SC6 etid
- Austin, TX6 etid
- San Antonio, TX5 etid
- Atlanta, GA5 etid
- Orlando, FL5 etid
- Sugar Land, TX4 etid
- Los Angeles, CA4 etid
- Macon, GA4 etid
- Columbus, OH4 etid
- Brandon, FL4 etid
- Redwood City, CA3 etid
- Reading, PA3 etid
- Philadelphia, PA3 etid
- Sterling Heights, MI3 etid
- Kansas City, KS3 etid
- Colorado Springs, CO3 etid
- Boulder, CO3 etid
- Farmington Hills, MI3 etid
- Madison, WI3 etid
- Staten Island, NY3 etid
- Lansing, MI3 etid
Pa eta
- Alabama5 etid
- Arizona3 etid
- Colorado4 etid
- Florid7 etid
- Georgia6 etid
- Kalifòni8 etid
- Kansas3 etid
- Michigan5 etid
- New Jersey3 etid
- North Carolina8 etid
- Ohio7 etid
- Pennsylvania4 etid
- South Carolina7 etid
- Texas6 etid
- Wisconsin4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
Ap rekriteFaz 2/3
Laj 18 a 70 · Tout sèks · Mizajou Sep 11, 2026 · NCT07598708A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 3, 2026 · NCT07455383A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07540364A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07675135A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 19, 2026 · NCT07625280A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Ap rekriteFaz 2/3
Laj 18 a 70 · Tout sèks · Mizajou Aug 7, 2026 · NCT06767683Decreasing Nightmares in Adults With Narcolepsy
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT06383806A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jun 29, 2026 · NCT07633301WAKIX® (Pitolisant) Pregnancy Registry
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Jun 12, 2026 · NCT05536011A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT07493265A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Apr 16, 2026 · NCT07096674Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 ak plis · Tout sèks · Mizajou Jan 22, 2026 · NCT04806620Extended-release Sodium Oxybate in Children
Ap rekriteFaz 2
Laj 7 a 17 · Tout sèks · Mizajou Nov 6, 2025 · NCT06809803Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 29, 2025 · NCT01793168SUNOSI® (Solriamfetol) Pregnancy Registry
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou May 14, 2024 · NCT06413420Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.